FIELD: medicine.
SUBSTANCE: invention relates to experimental medicine and can be used in determining the clinical effectiveness and safety of using inert gas argon as a neuroprotector in open traumatic brain injury (TBI). 3-fold 2-hour inhalation is performed with a gas mixture of the following composition: Ar 70%/O2 30% with flow of 0.5 l/min per one animal in 90 minutes after injury, in 24 hours after TBI and 48 hours after TBI.
EFFECT: method provides a neuroprotective effect in open TBI due to inhalation of an argon-oxygen respiratory mixture with an exposure duration of 2 hours.
1 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR BRAIN NEUROPROTECTION IN SIMULATING PHOTOINDUCED ISCHEMIC STROKE | 2023 |
|
RU2816057C1 |
| METHOD FOR BRAIN NEUROPROTECTION IN SIMULATING PHOTOINDUCED ISCHEMIC STROKE | 2023 |
|
RU2818909C1 |
| METHOD FOR INCREASING THE LEVEL OF CONSCIOUSNESS OF PATIENTS WITH PROLONGED IMPAIRMENT OF CONSCIOUSNESS AFTER TRAUMATIC BRAIN INJURY | 2022 |
|
RU2789004C1 |
| METHOD OF INHALATION SEDATION IN SEVERE ISCHEMIC STROKE | 2022 |
|
RU2797218C1 |
| METHOD FOR CORRECTION OF PATHOLOGY OF 2-AMINO-5-ETHYL-1,3,4-THIODIAZOLIUM-N-ACETYL-AMINOETHANOATE IN TRAUMATIC BRAIN INJURY | 2021 |
|
RU2766785C1 |
| METHOD FOR SIMULATING BRAIN CONTUSION OF MILD DEGREE | 2019 |
|
RU2725287C1 |
| METHOD FOR CORRECTING NEUROLOGICAL DEFICIT IN TRAUMATIC BRAIN INJURY | 2021 |
|
RU2758245C1 |
| ARTIFICIAL PEPTIDE FOR CRANIOCEREBRAL INJURY TREATMENT | 2023 |
|
RU2816919C1 |
| MEDICATION PRODUCING ANTI-ISCHEMIC, ANTIHYPOXIC AND ANTIAMNESTIC ACTION IN ACUTE PERIODE OF CRANIOCEREBRAL TRAUMA | 2009 |
|
RU2424802C2 |
| IN VIVO METHOD FOR DETERMINING BIOCOMPATIBILITY OF SCAFFOLDS FOR NEUROTRANSPLANTATION | 2021 |
|
RU2812608C2 |
